Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_assertion description "[One of such compound, crizotinib, is now approved in the United States for the treatment of lung cancer positive for ALK rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_assertion evidence source_evidence_literature NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_assertion SIO_000772 22614325 NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_assertion wasDerivedFrom befree-20140225 NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_assertion wasGeneratedBy ECO_0000203 NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP246086.RAqytpY8CzuSVlE4iyEMYWesexAkejp8JmdLLgw_rRuOU130_provenance.